Association Study of MAP3K1 SNPs and Risk Factors with Susceptibility to Esophageal Squamous Cell Carcinoma in a Chinese Population: A Case–Control Study

References

• World cancer research fund. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/oesophageal-cancer-statistics. Accessed 611, 2020.
   Google Scholar
• Pan D, Su M, Huang G, et al. MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case-control study. Cancer Cell Int. 2019;19:288. doi:10.1186/s12935-019-1012-x31754346
   PubMed Web of Science ®Google Scholar
• Chen J, Huang ZJ, Duan YQ, Xiao XR, Jiang JQ, Zhang R. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma. Asian Pac J Cancer Prev. 2012;13(10):5303‐5306. doi:10.7314/apjcp.2012.13.10.5303
   Google Scholar
• Yokoyama A, Kakiuchi N, Yoshizato T, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565(7739):312‐317. doi:10.1038/s41586-018-0811-x
   Web of Science ®Google Scholar
• Suo C, Yang Y, Yuan Z, et al. Alcohol intake interacts with functional genetic polymorphisms of aldehyde dehydrogenase (ALDH2) and alcohol dehydrogenase (ADH) to increase esophageal squamous cell cancer risk. J Thorac Oncol. 2019;14(4):712‐725. doi:10.1016/j.jtho.2018.12.023
   Web of Science ®Google Scholar
• Dumitrescu RG. Alcohol-induced epigenetic changes in cancer. Methods Mol Biol. 2018;1856:157–172. doi:10.1007/978-1-4939-8751-1_930178251
   PubMedGoogle Scholar
• Liang P, Zhang W, Wang W, et al. PLCE1 polymorphisms and risk of esophageal and gastric cancer in a northwestern Chinese population. Biomed Res Int. 2019;2019:9765191. doi:10.1155/2019/976519130931333
   PubMed Web of Science ®Google Scholar
• Batra R, Malhotra GK, Singh S, Are C. Managing squamous cell esophageal cancer. Surg Clin North Am. 2019;99(3):529‐541. doi:10.1016/j.suc.2019.02.006
   Web of Science ®Google Scholar
• Egyud MR, Tseng JF, Suzuki K. Multidisciplinary therapy of esophageal cancer. Surg Clin North Am. 2019;99(3):419–437. doi:10.1016/j.suc.2019.02.00231047033
   PubMed Web of Science ®Google Scholar
• Pham TT, Angus SP, Johnson GL. MAP3K1: genomic alterations in cancer and function in promoting cell survival or apoptosis. Genes Cancer. 2013;4(11–12):419‐426. doi:10.1177/1947601913513950
   Google Scholar
• Burotto M, Chiou VL, Lee JM, Kohn EC. The MAPK pathway across different malignancies: a new perspective. Cancer. 2014;120(22):3446–3456. doi:10.1002/cncr.2886424948110
   PubMed Web of Science ®Google Scholar
• Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci. 2011;36(6):320‐328. doi:10.1016/j.tibs.2011.03.006
   Web of Science ®Google Scholar
• Cammareri P, Vincent DF, Hodder MC, et al. TGFβ pathway limits dedifferentiation following WNT and MAPK pathway activation to suppress intestinal tumourigenesis. Cell Death Differ. 2017;24(10):1681–1693. doi:10.1038/cdd.2017.9228622298
   PubMed Web of Science ®Google Scholar
• Uhlik MT, Abell AN, Cuevas BD, Nakamura K, Johnson GL. Wiring diagrams of MAPK regulation by MEKK1, 2, and 3. Biochem Cell Biol. 2004;82(6):658–663. doi:10.1139/o04-11415674433
   PubMed Web of Science ®Google Scholar
• Hirai S, Noda K, Moriguchi T, et al. Differential activation of two JNK activators, MKK7 and SEK1, by MKN28-derived nonreceptor serine/threonine kinase/mixed lineage kinase 2. J Biol Chem. 1998;273(13):7406–7412. doi:10.1074/jbc.273.13.74069516438
   PubMed Web of Science ®Google Scholar
• Suddason T, Gallagher E. A RING to rule them all? Insights into the Map3k1 PHD motif provide a new mechanistic understanding into the diverse roles of Map3k1. Cell Death Differ. 2015;22(4):540–548. doi:10.1038/cdd.2014.23925613373
   PubMed Web of Science ®Google Scholar
• Shain AH, Garrido M, Botton T, et al. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet. 2015;47(10):1194–1199. doi:10.1038/ng.338226343386
   PubMed Web of Science ®Google Scholar
• Jara L, Gonzalez-Hormazabal P, Cerceño K, et al. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population. Breast Cancer Res Treat. 2013;137(2):559–569. doi:10.1007/s10549-012-2359-z23225170
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Charlaftis N, Suddason T, Wu X, Anwar S, Karin M, Gallagher E. The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines. EMBO J. 2014;33(21):2581–2596. doi:10.15252/embj.20148835125260751
   PubMed Web of Science ®Google Scholar
• Kuo SH, Yang SY, You SL, et al. Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer. Oncotarget. 2017;8(13):20925–20938. doi:10.18632/oncotarget.1499528178648
   PubMedGoogle Scholar
• Glubb DM, Maranian MJ, Michailidou K, et al. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. Am J Hum Genet. 2015;96(1):5–20. doi:10.1016/j.ajhg.2014.11.00925529635
   PubMed Web of Science ®Google Scholar
• Salem SM, Hamed AR, Mosaad RM. MTDH and MAP3K1 are direct targets of apoptosis-regulating miRNAs in colorectal carcinoma. Biomed Pharmacother. 2017;94:767–773. doi:10.1016/j.biopha.2017.07.15328802228
   PubMed Web of Science ®Google Scholar
• Guo Z, Sui L, Qi J, et al. miR-196b inhibits cell migration and invasion through targeting MAP3K1 in hydatidiform mole. Biomed Pharmacother. 2019;113:108760. doi:10.1016/j.biopha.2019.10876030889489
   PubMed Web of Science ®Google Scholar
• Zang WQ, Yang X, Wang T, et al. MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1. World J Gastroenterol. 2015;21(19):5867–5876. doi:10.3748/wjg.v21.i19.586726019450
   PubMed Web of Science ®Google Scholar
• Santarpia L, Lippman SM, El-Naggar AK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16(1):103–119. doi:10.1517/14728222.2011.64580522239440
   PubMed Web of Science ®Google Scholar
• Hu X, Zhai Y, Kong P, et al. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer. Cancer Lett. 2017;397:83–93. doi:10.1016/j.canlet.2017.03.03328366557
   PubMed Web of Science ®Google Scholar
• Sutter AP, Maaser K, Gerst B, Krahn A, Zeitz M, Scherübl H. Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase. Biochem Pharmacol. 2004;67(9):1701–1710. doi:10.1016/j.bcp.2004.01.00915081869
   PubMed Web of Science ®Google Scholar
• Wu K, Yang Y, Liu D, et al. Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway. Oncotarget. 2016;7(28):44572–44582. doi:10.18632/oncotarget.1006727323819
   PubMedGoogle Scholar
• O’Callaghan C, Fanning LJ, Houston A, Barry OP. Loss of p38δ mitogen-activated protein kinase expression promotes oesophageal squamous cell carcinoma proliferation, migration and anchorage-independent growth. Int J Oncol. 2013;43(2):405–415. doi:10.3892/ijo.2013.196823722928
   PubMed Web of Science ®Google Scholar
• Xia D, Tian S, Chen Z, Qin W, Liu Q. miR302a inhibits the proliferation of esophageal cancer cells through the MAPK and PI3K/Akt signaling pathways. Oncol Lett. 2018;15(3):3937–3943. doi:10.3892/ol.2018.778229456742
   PubMed Web of Science ®Google Scholar
• Mimura K, Shiraishi K, Mueller A, et al. The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer. J Immunol. 2013;191(12):6261–6272. doi:10.4049/jimmunol.130159724244023
   PubMed Web of Science ®Google Scholar
• Szczepankiewicz A, Sobkowiak P, Rachel M, et al. Multilocus analysis of candidate genes involved in neurogenic inflammation in pediatric asthma and related phenotypes: a case-control study. J Asthma. 2012;49(4):329–335. doi:10.3109/02770903.2012.66944222468730
   PubMed Web of Science ®Google Scholar
• Dominguez-Valentin M, Nakken S, Tubeuf H, et al. Identification of genetic variants for clinical management of familial colorectal tumors. BMC Med Genet. 2018;19(1):26. doi:10.1186/s12881-018-0533-929458332
   PubMed Web of Science ®Google Scholar
• Loke J, Pearlman A, Radi O, et al. Mutations in MAP3K1 tilt the balance from SOX9/FGF9 to WNT/β-catenin signaling. Hum Mol Genet. 2014;23(4):1073–1083. doi:10.1093/hmg/ddt50224135036
   PubMed Web of Science ®Google Scholar
• Esposito S, Ierardi V, Daleno C, et al. Genetic polymorphisms and risk of recurrent wheezing in pediatric age. BMC Pulm Med. 2014;14:162. doi:10.1186/1471-2466-14-16225326706
   PubMed Web of Science ®Google Scholar
• Das DK, Rahate SG, Mehta BP, Gawde HM, Tamhankar PM. Mutation analysis of mitogen activated protein kinase 1 gene in Indian cases of 46,XY disorder of sex development. Indian J Hum Genet. 2013;19(4):437–442. doi:10.4103/0971-6866.12437224497709
   PubMedGoogle Scholar